The International Classification of Functioning, Disability and Health and AIDS: a core set proposal

Authors

  • Cássia Maria Buchalla Universidade de São Paulo. Faculdade de Saúde Pública
  • Telma Regina Cavalheiro

DOI:

https://doi.org/10.11606/issn.2317-0190.v15i1a102908

Keywords:

Acquired Immunodeficiency Syndrome, International Classification of Functioning, Disability and Health, Quality of Life

Abstract

The advent of the highly active antiretroviral therapy (HAART) altered the natural history of AIDS, decreasing its mortality and the incidence of opportunistic diseases as well as increasing the life expectation of people living with AIDS. As a chronic disease, other issues started to be relevant and among them, treatment adherence, its adverse effects and the quality of life of people undergoing treatment. The International Classification of Functioning, Disability and Health (ICF) constitutes an adequate tool to identify the characteristics of functionality, the environment and personal conditions that interfere with quality of life. Tools for its application, called core sets, have been developed for several health conditions. Aiming at proposing a core set for AIDS, two preliminary steps of the proposed model were developed for the construction of these tools. The first phase, which consisted of a systematic review, searched in MEDLINE for articles that included the key words HAART and quality of life, published in English, from 200 to 2004. A total of 31 studies were selected that resulted in 87 concepts, 66 of which could be identified as ICF categories. These comprised the questions of the interview applied to 42 volunteers, who were patients at a Reference Center for STDs and AIDS in Sao Paulo, Brazil. Among the conditions more frequently associated with the treatment are changes in body image, the consequence of lipodystrophy, pointed out in 84% of the studies and 93% of the interviews. Alterations in digestive functions, intimate relationships and sexual function were important conditions identified in the study. The two phases defined 40 ICF categories as a preliminary core set proposal for AIDS patients.

Downloads

Download data is not yet available.

References

Brasil. Ministério da Saúde. Boletim Epidemiológico Aids e DST [texto na Internet]. Brasília (DF): Ministério da Saúde; 2007. [citado 2008 jan 15]. Disponível em: http://www.aids.gov.br/data/documents/storedDocuments/%7BB8EF5DAF-23AE-4891-AD36-1903553A3174%7D/%7B721527B6-FE7A-40DF-91C4098BE8C704E0%7D/Boletim2007_internet090108.pdf

Brasil. Ministério da Saúde. Ministério da Saúde. Secretaria de Vigilância em Saúde. Programa Nacional de DST e Aids. UNGASS - Resposta Brasileira 2005-2007 [texto na Internet]. Brasília (DF): Ministério da Saúde; 2008. [citado 2008 jan 15]. Disponível em: http://www.aids.gov.br/data/Pages/LUMISE77B47C8ITEMID831030A617AD46EBA93E3589E09C4C47PTBRIE.htm

Santos CP, Felipe YX, Braga PE, Ramos D, Lima RO, Segurado AC. Self-perception of body changes in persons living with HIV/AIDS: prevalence and associated factors. AIDS. 2005;19 Suppl 4:S14-21.

Santos ECM dos, França Jr. I, Lopes F. Qualidade de vida de pessoas vivendo com HIV/Aids em Sao Paulo. Rev Saúde Pública. 2007;41(Supl. 2):64-71.

OMS. CIF: Classificaçao Internacional de Funcionalidade, Incapacidade e Saúde. Sao Paulo: EDUSP; 2003.

Arthanat S, Nochajski SM, Stone J. The international classification of functioning, disability and health and its application to cognitive disorders. Disabil Rehabil. 2004;26(4):235-45.

Stucki G, Cieza A, Ewert T, Kostanjsek N, Chatterji S, Ustün TB. Application of the International Classification of Functioning, Disability and Health (ICF) in clinical practice. Disabil Rehabil. 2002;24(5):281-2.

Seidl EMF, Zannon CMLC. Qualidade de vida e saúde: aspectos conceituais e metodológicos. Cad Saúde Pública. 2004;20(2):580-8.

Stucki A, Cieza A, Michel F, Stucki G, Bentley A, Culebras A, et al. Developing ICF Core Sets for persons with sleep disorders based on the International Classification of Functioning, Disability and Health. Sleep Med. 2008;9(2):191-8.

Badía X, Podzamczer D, Moral I, Roset M, Arnaiz JA, Loncà M, et al. Health-related quality of life in HIV patients switching to twice-daily indinavir/ritonavir regimen or continuing with three-times-daily indinavir-based therapy. Antivir Ther. 2004;9(6):979-85.

Blanch J, Rousaud A, Martínez E, De Lazzari E, Peri JM, Milinkovic A, et al. Impact of lipodystrophy on the quality of life of HIV-1-infected patients. J Acquir Immune Defic Syndr. 2002;31(4):404-7.

Brechtl JR, Breitbart W, Galietta M, Krivo S, Rosenfeld B. The use of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection: impact on medical, palliative care, and quality of life outcomes. J Pain Symptom Manage. 2001;21(1):41-51.

Burgoyne R, Renwick R. Social support and quality of life over time among adults living with HIV in the HAART era. Soc Sci Med. 2004;58(7):1353-66.

Burgoyne RW, Rourke SB, Behrens DM, Salit IE. Long-term quality-of-life outcomes among adults living with HIV in the HAART era: the interplay of changes in clinical factors and symptom profile. AIDS Behav. 2004;8(2):151-63.

Carballo E, Cadarso-Suárez C, Carrera I, Fraga J, de la Fuente J, Ocampo A, et al. Assessing relationships between health-related quality of life and adherence to antiretroviral therapy. Qual Life Res. 2004;13(3):587-99.

Casado A, Badia X, Consiglio E, Ferrer E, González A, Pedrol E, et al. Health-related quality of life in HIV-infected naive patients treated with nelfinavir or nevirapine associated with ZDV/3TC (the COMBINE-QoL substudy).HIV Clin Trials. 2004;5(3):132-9.

Carrieri P, Spire B, Duran S, Katlama C, Peyramond D, François C, et al. Health-related quality of life after 1 year of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2003;32(1):38-47.

Cook JA, Cohen MH, Burke J, Grey D, Anastos K, Kirstein L, et al. Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive women. J Acquir Immune Defic Syndr. 2002;30(4):401-9.

Coplan PM, Cook JR, Carides GW, Heyse JF, Wu AW, Hammer SM, et al. Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine. Clin Infect Dis. 2004;39(3):426-33.

Corless IB, Nicholas PK, McGibbon CA, Wilson C. Weight change, body image, and quality of life in HIV disease: a pilot study. Appl Nurs Res. 2004;17(4):292-6.

Dorz S, Lazzarini L, Cattelan A, Meneghetti F, Novara C, Concia E, et al. Evaluation of adherence to antiretroviral therapy in Italian HIV patients. AIDS Patient Care STDS. 2003;17(1):33-41.

Gill CJ, Griffith JL, Jacobson D, Skinner S, Gorbach SL, Wilson IB. Relationship of HIV viral loads, CD4 counts, and HAART use to health-related quality of life. J Acquir Immune Defic Syndr. 2002;30(5):485-92.

Hughes J, Jelsma J, Maclean E, Darder M, Tinise X. The health-related quality of life of people living with HIV/AIDS. Disabil Rehabil. 2004;26(6):371-6.

Jia H, Uphold CR, Wu S, Reid K, Findley K, Duncan PW. Health-related quality of life among men with HIV infection: effects of social support, coping, and depression. AIDS Patient Care STDS. 2004;18(10):594-603.

Johnson MO, Stallworth T, Neilands TB. The drugs or the disease? Causal attributions of symptoms held by HIV-positive adults on HAART. AIDS Behav. 2003;7(2):109-17.

Krentz HB, Gill MJ. The impact on health-related quality of life of treatment interruptions in HIV-1-infected patients. AIDS. 2003;17(4):631-3.

Bucciardini R, Murri R, Guarinieri M, Starace F, Martini M, Vatrella A, et al. ISSQoL: a new questionnaire for evaluating the quality of life of people living with HIV in the HAART era. Qual Life Res. 2006;15(3):377-90.

Mirmirani P, Maurer TA, Berger TG, Sands LP, Chren MM. Skin-related quality of life in HIV-infected patients on highly active antiretroviral therapy. J Cutan Med Surg. 2002;6(1):10-5.

Moyle GJ, Daar ES, Gertner JM, Kotler DP, Melchior JC, O'brien F, et. al. Growth hormone improves lean body mass, physical performance, and quality of life in subjects with HIV-associated weight loss or wasting on highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2004;35(4):367-75.

Murri R, Fantoni M, Del Borgo C, Visona R, Barracco A, Zambelli A, et al. Determinants of health-related quality of life in HIV-infected patients. AIDS Care. 2003;15(4):581-90.

Nieuwkerk PT, Gisolf EH, Reijers MH, Lange JM, Danner SA, Sprangers MA, et al. Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection. AIDS. 2001;15(15):1985-91.

Penedo FJ, Gonzalez JS, Dahn JR, Antoni M, Malow R, Costa P, et al. Personality, quality of life and HAART adherence among men and women living with HIV/AIDS. J Psychosom Res. 2003;54(3):271-8.

Préau M, Leport C, Salmon-Ceron D, Carrieri P, Portier H, Chene G, et al. Health-related quality of life and patient-provider relationships in HIV-infected patients during the first three years after starting PI-containing antiretroviral treatment. AIDS Care. 2004;16(5):649-61.

Rabkin JG, Ferrando SJ, Lin SH, Sewell M, McElhiney M. Psychological effects of HAART: a 2-year study. Psychosom Med. 2000;62(3):413-22.

Safren SA, Radomsky AS, Otto MW, Salomon E. Predictors of psychological well-being in a diverse sample of HIV-positive patients receiving highly active antiretroviral therapy. Psychosomatics. 2002;43(6):478-85.

Saunders DS, Burgoyne RW. Evaluating health-related wellbeing outcomes among outpatient adults with human immunodeficiency virus infection in the HAART era. Int J STD AIDS. 2002;13(10):683-90.

Tramarin A, Campostrini S, Postma MJ, Calleri G, Tolley K, Parise N, et al. A multicentre study of patient survival, disability, quality of life and cost of care: among patients with AIDS in northern Italy. Pharmacoeconomics. 2004;22(1):43-53.

Tramarin A, Parise N, Campostrini S, Yin DD, Postma MJ, Lyu R, et al. Association between diarrhea and quality of life in HIV-infected patients receiving highly active antiretroviral therapy. Qual Life Res. 2004;13(1):243-50.

Tozzi V, Balestra P, Murri R, Galgani S, Bellagamba R, Narciso P, et al. Neurocognitive impairment influences quality of life in HIV-infected patients receiving HAART. Int J STD AIDS. 2004;15(4):254-9.

Yen CF, Tsai JJ, Lu PL, Chen YH, Chen TC, Chen PP, et al. Quality of life and its correlates in HIV/AIDS male outpatients receiving highly active antiretroviral therapy in Taiwan. Psychiatry Clin Neurosci. 2004;58(5):501-6.

Published

2008-03-09

Issue

Section

Original Article

How to Cite

1.
Buchalla CM, Cavalheiro TR. The International Classification of Functioning, Disability and Health and AIDS: a core set proposal. Acta Fisiátr. [Internet]. 2008 Mar. 9 [cited 2024 Jul. 18];15(1):42-8. Available from: https://periodicos.usp.br/actafisiatrica/article/view/102908